midazolam has been researched along with Pneumonia, Viral in 2 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiserud, Y | 1 |
| Rosland, JH | 1 |
| Jackson, T | 1 |
| Hobson, K | 1 |
| Clare, H | 1 |
| Weegmann, D | 1 |
| Moloughney, C | 1 |
| McManus, S | 1 |
2 other studies available for midazolam and Pneumonia, Viral
| Article | Year |
|---|---|
Relieving the sensation of suffocation in patients dying with COVID-19.
Topics: Algorithms; Analgesics, Opioid; Asphyxia; Betacoronavirus; Coronavirus Infections; COVID-19; Fear; H | 2020 |
End-of-life care in COVID-19: An audit of pharmacological management in hospital inpatients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Betacoronavirus; Biopharmaceutics; Coronavirus I | 2020 |